Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
13
Views
0
CrossRef citations to date
0
Altmetric
Articles

The roles of MMP-2/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats

Qian LiDepartment of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan, China.
,
Shu-zhen SunDepartment of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan, China.
,
Yi WangDepartment of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan, China.Correspondence[email protected]
,
Yong-jie TianDepartment of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan, China.
&
Ming-hua LiuDepartment of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan, China.
Pages 485-491 | Received 09 Feb 2007, Accepted 25 Jun 2007, Published online: 23 May 2017

References

  • Codinach Huix P, Freixa Pamias R. Diabetic cardiomyopa-thy: concept, heart function, and pathogenesis [in Spanish]. An Med Interna 2002; 19: 313–20.
  • Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 2004; 18: 828–35.
  • Manabe I, Shindo T, Nagai R. Gene expression in fibrob-lasts and fibrosis: Involvement in cardiac hypertrophy. Circ Res 2002; 91: 1103–13.
  • Deschamps AM, Apple KA, Leonardi AH, McLean JE, Yarbrough WM, Stroud RE, Clark LL, Sample JA, Spinale FG. Myocardial interstitial matrix metalloproteinase activ-ity is altered by mechanical changes in LV load interaction with the angiotensin type 1 receptor. Circ Res 2005; 96: 1110–8.
  • Singh RB, Dandekar SP, Elimban V, Gupta SK, Dhalla NS. Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem 2004; 263: 241–56.
  • Spinale FG, Coker ML, Bond BR, Zenner JL. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000; 46: 225–38.
  • Scognamiglio R, Avogaro A, Negut C, Piccolotto R, Vigili de Kreutzenberg S, Tiengo A. Early myocardial dysfunction in the diabetic heart: current research and clinical applica-tions. Am J Cardiol 2004; 93: 17A-20A.
  • Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krumb H, Wilkinson-Berkac J, Gilbert RE. Tranilast atten-uates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-f3. Cardiovasc Res 2005; 65: 694–701.
  • Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 2004; 82: 813–23.
  • Iltis I, Kober F, Desrois M, Dalmasso C, Lan C, Portha B, Cozzone PJ, Bernard M. Defective myocardial blood flow and altered function of the left ventricle in type 2 diabetic rats: a noninvasive in vivo study using perfusion and cine magnetic resonance imaging. Invest Radiol 2005; 40: 19–26.
  • Podlesny M. Diabetic cardiomyopathy [in Polish]. Pol Merkur Lekarski 2003; 15: 476–9.
  • Scognamiglio R, Negut C, de Kreutzenberg SV, Palisi M, Tiengo A, Avogaro A. Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients. Clin Cardiol 2005; 28: 93–9.
  • D’Armiento J. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Car-diovasc Med 2002; 12: 97–101.
  • Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J1998; 12: 1075-95.
  • Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 31: 21491–4.
  • Cleutjens JP. The role of matrix metalloproteinases in heart disease. Cardiovasc Res 1996; 32(5): 816–21.
  • Dollery CM, McEwan JR, Henney AM. Matrix metallo-proteinases and cardiovascular disease. Circ Res 1995; 77(5): 863–8.
  • Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 2001; 88(12): 1291–8.
  • Bollano E, Omerovic E, Svensson H, Waagstein F, Fu M. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in dia-betic rats. Int J Cardiol 2007; 114: 195–201.
  • Lee SW, Song KE, Shin DS, Ahn SM, Ha ES, Kim DJ, Nam MS, Lee KW Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 dia-betes. Diabetes Res Clin Pract 2005; 69: 175–9.
  • Tayebjee MH, Lim HS, Macfadyen RJ, Lip GY. Matrix met-alloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year’s cardiovascular risk reduction therapy. Diabetes Care 2004; 27: 2049–51.
  • Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix met-alloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 2005; 85: 597–607.
  • Wall SJ, Sampson MJ, Levell N, Murphy G. Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol 2003; 149: 13–6.
  • Dong FQ, Li H, Cai WM, Tao J, Li Q, Ruan Y, Zheng FP, Zhang Z. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats. Chin Med J (Engl) 2004; 117: 1040–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.